Concourse Financial Group Securities’s ENDRA Life Sciences Inc. Warrants NDRAW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Hold |
0
| – | – | – | 11269 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 11016 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 10543 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 9787 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 9208 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 8538 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 7765 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 7333 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 7093 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 6962 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 6867 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 6697 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 6649 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 6488 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 6398 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 6233 |
|